NSC
57
-5
NWS
69
3
ADM
51
-6
PWR
71
2
CAH
58
-3
DAL
64
2
STZ
44
-10
CMG
58
-5
T
53
3
HST
52
-5
EXC
43
-4
TGNA
56
2
PYPL
37
-2
WAT
57
2
MSFT
58
-3
SYK
42
3
ECL
60
-2
QCOM
57
2
VNO
63
4
BF.B
46
-7
NSC
57
-5
NWS
69
3
ADM
51
-6
PWR
71
2
CAH
58
-3
DAL
64
2
STZ
44
-10
CMG
58
-5
T
53
3
HST
52
-5
EXC
43
-4
TGNA
56
2
PYPL
37
-2
WAT
57
2
MSFT
58
-3
SYK
42
3
ECL
60
-2
QCOM
57
2
VNO
63
4
BF.B
46
-7
Financhill
Back

Harmony Biosciences Holdings 10K Form

Buy
54

HRMY
Harmony Biosciences Holdings

Last Price:
29.08
Seasonality Move:
-16.46%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive HRMY News And Ratings

See the #1 stock for the next 7 days that we like better than HRMY

HRMY Financial Statistics

Sales & Book Value

Annual Sales: $437.86M
Cash Flow: $63.1M
Price / Cash Flow: 10.61
Annual Sales: $8.22
Price / Book: 3.58

Profitability

EPS (TTM): 2.46000
Net Income (TTM): $150.76M
Gross Margin: $354.37M
Return on Equity: 34.96%
Return on Assets: 21.11%

Harmony Biosciences Holdings Earnings Forecast

Key Harmony Biosciences Holdings Financial Ratios

  • The Gross Profit Margin over the past 5 years for HRMY is 80.93%.
  • The Selling, General & Administrative Expenses for HRMY have been equal to 37.30% of Gross Profit Margin.
  • The Research & Development expenses have been 16.19% of Revenue.
  • The Interest Expense is 8.64% of Operating Income.
  • The Net Earning history of HRMY is 41.44% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 3 years.

Harmony Biosciences Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Healthcare
Current Symbol: HRMY
Website: harmonybiosciences.com

Debt

Debt-to-Equity Ratio: 0.41
Current Ratio: 4.12
Quick Ratio: 3.9

Price-to-Earnings

Trailing P/E Ratio: 9.9
Forward P/E Ratio: 6.99

HRMY Technical Analysis vs Fundamental Analysis

Buy
54
Harmony Biosciences Holdings (HRMY) is a Buy

Is Harmony Biosciences Holdings a Buy or a Sell?